Big Pharma Stocks Eli Lilly, AbbVie and Pfizer Share Q3 Results

Major pharmaceutical players Eli Lilly (NYSE:LLY), AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) reported mixed Q3 results, with each company facing distinct market forces, ranging from supply issues to financial constraints. In its latest quarterly report, released on Wednesday (October 30), Eli Lilly missed on sales expectations for Zepbound, its popular weight-loss drug, and Mounjaro, its diabetes…

Read More

Fission Uranium Grows Athabasca Basin Portfolio by Staking New Assets

Fission Uranium (TSX:FCU,OTCQX:FCUUF) has expanded its uranium exploration portfolio in and around Northern Saskatchewan’s Athabasca Basin by staking four additional properties. According to the company’s Thursday (October 31) press release, the new sites, called Typhoon, Corsair, Merlin and Seahawk, encompass thousands of hectares and are situated near established uranium-producing areas and deposits. Typhoon, which is…

Read More

Harris asked how she’s ‘feeling’ 48 hours from election, tells reporters Trump ‘lost’ in 2020

Democratic presidential candidate Vice President Harris was asked at the top of a press gaggle of reporters in Detroit, Michigan, ‘Simply, how are you feeling and have you submitted your ballot?’  Harris, 48 hours from Election Day, admitted that ‘everyone’s a little tired’ and ‘sleep-deprived.’  ‘I am feeling great, I am looking forward to these…

Read More

Astral’s Group Gold Mineral Resource Increases to 1.46Moz with Updated Feysville MRE

Astral Resources NL (ASX: AAR) (Astral or the Company) is pleased to report an updated JORC compliant (2012 Edition) Mineral Resource Estimate (MRE) for the 100%-owned Feysville Gold Project (Feysville), located 14km south of Kalgoorlie in Western Australia (refer to Figure 2 below). HIGHLIGHTS: Updated JORC 2012 Mineral Resource Estimate (MRE) of 5.0Mt at 1.2g/t…

Read More
Back To Top